US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (221)
  • Diseases & Conditions (4421)
  • Drug Delivery (185)
  • Therapeutic Area (7004)
  • Vaccines (643)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

5  6  7  8    10    12  13  14  
Oxytocin Receptor Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Oxytocin Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
P2X Receptor Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The P2X Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
P2X7 Receptor Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The P2X7 Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Sciatic Pain-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Sciatic Pain Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Sciatic Pain- Pipeline ...  |  read more...
USD 1,250
Seasonal Allergic Rhinitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Seasonal Allergic Rhinitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Septic Shock-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Septic Shock Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Septic Shock- Pipeline ...  |  read more...
USD 1,250
Severe Psoriasis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Severe Psoriasis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Severe Psoriasis- Pipeline ...  |  read more...
USD 1,250
Skin And Skin Structure Infections (SSSI)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (SSSI). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Skin And Skin Structure Infections (SSSI) Report helps to identify emerging players with ...  |  read more...
USD 1,250
Skin And Skin Structure Infections (SSSI) Caused By Bacteria-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... the Skin And Skin Structure Infections (SSSI) Caused By Bacteria. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Skin And Skin Structure ...  |  read more...
USD 1,250
Skin And Skin Structure Infections by S.Pneumoniae-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Structure Infections by S.Pneumoniae. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Skin And Skin Structure Infections by S.Pneumoniae Report helps to ...  |  read more...
USD 1,250
P2Y12 Platelet ADP Receptor Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The P2Y12 Platelet ADP Receptor Antagonists Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Skin Inflammation-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Skin Inflammation Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Skin Inflammation- Pipeline ...  |  read more...
USD 1,250
Smoking Cessation-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Smoking Cessation Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Smoking Cessation- Pipeline ...  |  read more...
USD 1,250
Spasticity-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Spasticity Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spasticity- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Spinal Stenosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Spinal Stenosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spinal Stenosis- Pipeline ...  |  read more...
USD 1,250
Spondylitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Spondylitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spondylitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Squamous Non-Small Cell Lung Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Squamous Non-Small Cell Lung Cancer Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
PBP1A Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The PBP1A Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, PBP1A Inhibitors- ...  |  read more...
USD 1,250
Steatohepatitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Steatohepatitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Steatohepatitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Subacute Cutaneous Lupus Erythematosus (SCLE)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Subacute Cutaneous Lupus Erythematosus (SCLE) Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
Systemic Juvenile Idiopathic Arthritis (SJIA)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Systemic Juvenile Idiopathic Arthritis (SJIA) Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
Systemic Sclerosis (Scleroderma)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Systemic Sclerosis (Scleroderma) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
PDE 3 Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The PDE 3 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Penicillin-Binding Proteins (PBPs) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Penicillin-Binding Proteins (PBPs) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Peptidoglycan Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Peptidoglycan Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Peptidoglycan Inhibitors- ...  |  read more...
USD 1,250
5  6  7  8    10    12  13  14